Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - October 2001

  1. Principles of vaccination J.Am.Vet.Med.Assoc.  9-1-2001, 219 (5): 575-576.

  2. Bos, J. M., Rumke, H. C., Welte, R., Postma, M. J., and Jager, J. C.  Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program  Vaccine.  10-12-2001, 20 (1-2): 202-207.

  3. Cox, R. J., Mykkeltvedt, E., Sjursen, H., and Haaheim, L. R.  The effect of zanamivir treatment on the early immune response to influenza vaccination  Vaccine.  9-14-2001, 19 (32): 4743-4749.

  4. Danovaro-Holliday, M. C., Zimmerman, L., and Reef, S. E.  Preventing Congenital Rubella Syndrome (CRS) through Vaccination of Susceptible Women of Childbearing Age J.Womens Health Gend.Based.Med.  2001, 10 (7): 617-619.

  5. Diez-Domingo, J., Pereiro, I., Morant, A., Gimeno, C., San Martin, M., and Gonzalez, A.  Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain  J.Infect.  2001, 42 (4): 257-260.

  6. Edmunds, W. J., Gay, N. J., Henao Restrepo, A. M., Olive, J., and Bele, O.  Measles vaccination in Africa: by how much could routine coverage be improved?  Vaccine.  10-12-2001, 20 (1-2): 16-18.

  7. Fjallbrant, H., Ridell, M., and Larsson, L. O.  The tuberculin skin test in reaction to immunological in vitro reactions in BCG-vaccinated healthcare workers  Eur.Respir.J.  2001, 18 (2): 376-380.

  8. Funada, H. and Abe, Y.  [Two-step tuberculin testing and BCG vaccination in the personnel of a medical and pharmaceutical university] Kekkaku.  2001, 76 (8): 563-569.

  9. Gans, H., Yasukawa, L., Rinki, M., DeHovitz, R., Forghani, B., Beeler, J., Audet, S., Maldonado, Y., and Arvin, A. M.  Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months  J.Infect.Dis.  10-1-2001, 184 (7): 817-826.

  10. Gardner, E. M., Bernstein, E. D., Dran, S., Munk, G., Gross, P., Abrutyn, E., and Murasko, D. M.  Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population Vaccine.  9-14-2001, 19 (32): 4610-4617.

  11. Ghosh, C.  Periorbital and orbital cellulitis after H. influenza B vaccination Ophthalmology.  2001, 108 (9): 1514-1515.

  12. Grime, P.  BCG re-vaccination Thorax.  2001, 56 (9): 741-742.

  13. Hedlund, J., Langer, B., Konradsen, H. B., and Ortqvist, A. 
    Negligible adjuvant effect for antibody responses and frequent adverse events associated with IL-12 treatment in humans vaccinated with pneumococcal polysaccharide Vaccine.  10-12-2001, 20 (1-2): 164-169.

  14. Juretzko, P., Fabian-Marx, T., Haastert, B., Giani, G., von Kries, R., and Wirsing von Konig, C. H. 
    Pertussis in Germany: regional differences in management and vaccination status of hospitalized cases Epidemiol.Infect.  2001, 127 (1): 63-71.

  15. Kharabsheh, S., Al Otoum, H., Clements, J., Abbas, A., Khuri-Bulos, N., Belbesi, A., Gaafar, T., and Dellepiane, N.  Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan  Bull.World Health Organ.  2001, 79 (8): 764-770.

  16. Lehrke, P., Nuebling, M., Hofmann, F., and Stoessel, U.  Attitudes of homoeopathic physicians towards vaccination  Vaccine.  9-14-2001, 19 (32): 4859-4864.

  17. McDade, T. W., Beck, M. A., Kuzawa, C., and Adair, L. S.  Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence Am.J.Clin.Nutr.  2001, 74 (4): 543-548.

  18. Moraga Llop, F. A. and Campins, Marti M.  [Importance of influenza in the child. Intranasal influenza vaccine: another systematic vaccination?] An Esp.Pediatr.  2000, 53 (4): 299-304.

  19. Niu, M. T., Erwin, D. E., and Braun, M. M.  Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination  Vaccine.  9-14-2001, 19 (32): 4627-4634.

  20. Ogura, M. and Ichimura, H.  [Measles epidemic and investigation of the vaccination history in Chiba Prefecture in 2000. A report from Chiba epidemiological surveillance of tuberculosis and infectious diseases]  Kansenshogaku Zasshi.  2001, 75 (8): 686-691.

  21. Pesanti, E. L.  Immunologic defects and vaccination in patients with chronic renal failure Infect.Dis.Clin.North Am.  2001, 15 (3): 813-832.

  22. Peters, P. H., Jr., Gravenstein, S., Norwood, P., De, Bock, V, Van Couter, A., Gibbens, M., von Planta, T. A., and Ward, P.  Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population J.Am.Geriatr.Soc.  2001, 49 (8): 1025-1031.

  23. Schneider, E. C., Cleary, P. D., Zaslavsky, A. M., and Epstein, A. M.  Racial Disparity in Influenza Vaccination: Does Managed Care Narrow the Gap Between African Americans and Whites?  JAMA.  9-26-2001, 286 (12): 1455-1460.

  24. Sen, S., Cloete, Y., Hassan, K., and Buss, P.  Adverse events following vaccination in premature infants  Acta Paediatr.  2001, 90 (8): 916-920.

  25. Suker, J. and Feavers, I. M.  Prospects offered by genome studies for combating meningococcal disease by vaccination  Pharmacogenomics.  2001, 2 (3): 273-283.

  26. Takao, S., Ishida, T., Shimazu, Y., Fukuda, S., Noda, M., and Miyazaki, K.  Genetic differentiation of a measles virus isolated from a case occurring 15 days after measles vaccination  Jpn.J.Infect.Dis.  2001, 54 (3): 119-120.

  27. Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Sundh, V., Lagergard, T., Lind-Brandberg, L., Zackrisson, G., White, J., Cicirello, H., Fusco, J., and Robbins, J. B.  Mass vaccination of children with pertussis toxoid-decreased incidence in both vaccinated and nonvaccinated persons Clin.Infect.Dis.  10-1-2001, 33 (7): 1004-1010.

  28. Van Amburgh, J. A., Waite, N. M., Hobson, E. H., and Migden, H.  Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign  Pharmacotherapy.  2001, 21 (9): 1115-1122.

  29. van der Velden, A. M., Mulder, A. H., Hartkamp, A., Diepersloot, R. J., Velzen-Blad, H., and Biesma, D. H.  Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients  European Journal of Internal Medicine   2001, 12 (5): 420-424.

  30. Wahid, S. T., Nag, S., Bilous, R. W., Marshall, S. M., and Robinson, A. C.  Audit of influenza and pneumococcal vaccination uptake in diabetic patients attending secondary care in the Northern Region  Diabet.Med.  2001, 18 (7): 599-603.

  31. Zanetta, R. A., Amaku, M., Azevedo, R. S., Zanetta, D. M., Burattini, M. N., and Massad, E.  Optimal age for vaccination against measles in the State of Sao Paulo, Brazil, taking into account the mother's serostatus  Vaccine.  10-12-2001, 20 (1-2): 226-234.

Back to Top